Carlson

The topical nasal decongestant oxymetazoline did not reduce the rate of middle-ear barotrauma in patients having hyperbaric oxygen therapy.

Clinical Bottom Line:

  1. No evidence that topical decongestants reduce middle ear barotrauma during hyperbaric therapy.

Citation/s:1. Carlson S, Jones J, Brown M, Hess C. Prevention of hyperbaric-associated middle ear barotrauma. Annals of Emergency Medicine 1992; 21:1468-1471.

Clinical Scenario:A patient presents for hyperbaric oxygen therapy. We wondered if topical nasal decongestants would decrease the incidence of aural barotrauma.

Three-part Question:In patients undergoing hyperbaric oxygen therapy, does the pre-hyperbaric use of topical nasal decongestant compared to no specific pre-treatment, result in less middle ear barotrauma?

Search Terms:ear, middle, barotrauma, nasal decongestants

The Study:Double-blinded concealed randomised controlled trial with intention-to-treat. Adults requiring hyperbaric therapy for acute carbon monoxide poisoning and able to make informed consent.

Control group (N = 30; 30 analysed):Two sprays of sterile water into each nostril at least 15 minutes prior to hyperbaric exposure at 2.4 ATA.

Experimental group (N = 30; 30 analysed):Two sprays of oxymetazoline hydrochloride into each nostril at least 15 minutes prior to hyperbaric exposure at 2.4 ATA.

The Evidence:

Outcome

Water group

Oxymet group

Relative risk increase

Absolute risk increase

NNH

Teed score > zero after treatment

0.4

0.47

17%

0.067

15

95% CI:

-46% to 79%

-0.18 to 0.32

NNH 3 to INF

NNT 5 to INF

Ear pain on compression

0.2

0.3

50%

0.1

10

 

95% CI:

-59% to 100%

-0.12 to 0.32

NNH 3 to INF

NNT 8 to INF

Asymptomatic compression

0.333

0.367

10%

-0.034

29

 

95% CI:

-62% to 83%

-0.21 to 0.28

NNH 4 to INF

NNT 5 to INF

Comments:

1. Well-designed study with 80% power to detect 50% reduction in the incidence of barotrauma.

2. All CO poisoned patients, probably treated in a monoplace chamber.

3. Most patients experienced some discomfort in the ears.

4. Compression rate not specified.

Appraised by:Mike Bennett, Dept of Diving and Hyperbaric Medicine, Prince of Wales HospitalSydney; Thursday, 04 February, 1999

Expiry date:June 2022

 

Sumhorsa.gif

 

BACK